Performance of ACLX Arcellx | 105.3% in 12m
Compare ACLX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Arcellx with its related Sector/Index XBI
Performance Duell ACLX vs XBI
| TimeFrame | ACLX | XBI |
|---|---|---|
| 1 Week | 7.11% | 2.09% |
| 1 Month | 22.2% | 4.45% |
| 3 Months | 79.7% | 7.71% |
| 6 Months | 76.5% | 11.24% |
| 12 Months | 105.3% | 44.21% |
| YTD | 65.6% | 11.67% |
| Rel. Perf. 1m | 0.59 | |
| Rel. Perf. 3m | 4.15 | |
| Rel. Perf. 6m | 4.10 | |
| Rel. Perf. 12m | 3.20 | |
| Spearman 1m | 0.07 | 0.236 |
| Spearman 3m | 0.90 | -0.066 |
Is Arcellx a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Arcellx is currently (November 2024)
neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -17.13 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACLX as of November 2024 is 113.69. This means that ACLX is currently undervalued and has a potential upside of +30.5% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ACLX as of November 2024 is 113.69. This means that ACLX is currently undervalued and has a potential upside of +30.5% (Margin of Safety).
Is ACLX a buy, sell or hold?
- Strong Buy: 13
- Buy: 6
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: ACLX is performing better - Values below 0%: ACLX is underperforming
Compare ACLX with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 7.98% | 20.66% | 64.19% | 71.10% |
| US NASDAQ 100 | QQQ | 8.70% | 20.13% | 64.39% | 71.02% |
| US Dow Jones Industrial 30 | DIA | 3.44% | 17.99% | 63.03% | 74.76% |
| German DAX 40 | DAX | 8.81% | 23.82% | 72.49% | 79.70% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.89% | 43.03% | 65.27% | 91.91% |
| Hongkong Hang Seng | HSI | 6.94% | 33.97% | 68.60% | 98.35% |
| India NIFTY 50 | INDA | 8.00% | 24.58% | 71.99% | 81.35% |
| Brasil Bovespa | EWZ | 6.58% | 25.28% | 86.01% | 110.61% |
ACLX Arcellx vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.22% | 18.38% | 61.35% | 65.56% |
| Consumer Discretionary | XLY | 5.76% | 18.21% | 63.20% | 77.71% |
| Consumer Staples | XLP | 6.53% | 21.96% | 68.62% | 84.49% |
| Energy | XLE | 4.46% | 25.80% | 78.30% | 96.41% |
| Financial | XLF | 7.56% | 18.64% | 61.93% | 64.29% |
| Health Care | XLV | 7.48% | 24.30% | 71.17% | 88.15% |
| Industrial | XLI | 6.76% | 21.55% | 66.05% | 68.88% |
| Materials | XLB | 7.59% | 23.51% | 71.56% | 83.37% |
| Real Estate | XLRE | 7.11% | 20.82% | 56.18% | 74.31% |
| Technology | XLK | 9.87% | 20.82% | 65.42% | 73.04% |
| Utilities | XLU | 8.27% | 23.59% | 60.87% | 74.07% |
| Aerospace & Defense | XAR | 8.21% | 23.21% | 65.27% | 73.54% |
| Biotech | XBI | 5.02% | 17.78% | 65.29% | 61.04% |
| Homebuilder | XHB | 4.21% | 24.47% | 65.26% | 49.14% |
| Retail | XRT | 5.04% | 19.64% | 71.82% | 78.05% |
Does Arcellx outperform its market, is ACLX a Sector Leader?
Yes, over the last 12 months Arcellx (ACLX) made 105.25%, while its related Sector, the SPDR S&P Biotech (XBI) made 44.21%.
Over the last 3 months ACLX made 79.74%, while XBI made 7.71%.
Yes, over the last 12 months Arcellx (ACLX) made 105.25%, while its related Sector, the SPDR S&P Biotech (XBI) made 44.21%.
Over the last 3 months ACLX made 79.74%, while XBI made 7.71%.
| Period | ACLX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 22.23% | 4.45% | 1.57% |
| 3 Months | 79.74% | 7.71% | 11.81% |
| 12 Months | 105.25% | 44.21% | 34.15% |